Fondaparinux (CAS 104993-28-4)
Alternate Names:
Natural heparin pentasaccharide Arixtra CHEBI:61033
CAS Number:
104993-28-4
Molecular Weight:
1508.30
Molecular Formula:
C31H53N3O49S8
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Fondaparinux (CAS 104993-28-4) References
- How I treat pediatric venous thromboembolism in the DOAC era. | Bhat, RV., et al. 2024. Blood. 143: 389-403. PMID: 37390311
- Ilio-femoral venous stenting for post-thrombotic syndrome in women of childbearing age: efficacy and impact of pregnancy-a multi-center study by the French Society of Cardiovascular Imaging. | Marcelin, C., et al. 2024. Eur Radiol. 34: 1567-1577. PMID: 37653047
- Mesoglycan for the secondary prevention of superficial vein thrombosis: a randomized, controlled, double-blind study (METRO Study)-rationale and protocol. | Camporese, G., et al. 2024. J Thromb Thrombolysis. 57: 226-234. PMID: 37932589
- Antithrombotic prophylaxis following total hip arthroplasty: a level I Bayesian network meta-analysis. | Migliorini, F., et al. 2024. J Orthop Traumatol. 25: 1. PMID: 38194191
- External Trigger Free Charge Switchable Cationic Ligands in the Design of Safe and Effective Universal Heparin Antidote. | La, CC., et al. 2024. Adv Healthc Mater. e2400108. PMID: 38537246
- Pharmacological Thromboprophylaxis for VTE Post-Endovenous Ablation of Varicose Veins: Network Meta-Analysis. | Westby, D., et al. 2024. Vasc Endovascular Surg. 58: 623-632. PMID: 38610070
- Donor Preactivation-Based Glycan Assembly: from Manual to Automated Synthesis. | Yao, W. and Ye, XS. 2024. Acc Chem Res. 57: 1577-1594. PMID: 38623919
- The efficacy and safety of direct oral anticoagulants in the treatment of the acute phase of heparin-induced thrombocytopenia: A systematic review. | Sadowski, C. and Reinert, JP. 2024. Am J Health Syst Pharm.. PMID: 38651828
- Overview of the current procedures in synthesis of heparin saccharides. | Zhao, S., et al. 2024. Carbohydr Polym. 339: 122220. PMID: 38823902
- Chemokine Oligomers and the Impact of Fondaparinux Binding. | Szekeres, GP., et al. 2024. J Am Soc Mass Spectrom. 35: 1550-1555. PMID: 38836362
- Distinct antithrombin activation modes for fondaparinux and natural heparins detected using millisecond hydrogen deuterium exchange and collision induced unfolding. | Listigovers, A., et al. 2024. Int J Biol Macromol. 273: 132868. PMID: 38838881
- Multifaceted Cerebral Venous Thrombosis With Extensive Intra-cerebral Hemorrhage in a Young Man With Mitral Valve Replacement Due to Thrombosis and IgA Nephropathy: A Challenging Case Report From Saudi Arabia. | AlQahtani, BG., et al. 2024. Cureus. 16: e60016. PMID: 38854275
- Effect of a 3-Month Single-Drug Approach Using Rivaroxaban for Symptomatic Proximal Deep Vein Thrombosis. | Shimizu, K., et al. 2024. Circ Rep. 6: 217-222. PMID: 38860185
Inhibitor of:
ADF, BPNT1, DIC, Factor IX, Factor V, Factor VII, Factor VIII, Factor X, Factor XII, Factor XIII A, Fibrinogen β, HABP2, NCAG1, OTTMUSG00000019145, plasma kallikrein, PN-1, Protein Z, and TFPI-2.Activator of:
HCII, Hirudin, HS3ST6, Kininogen, and TLCK.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Fondaparinux, 10 mg | sc-507424 | 10 mg | $297.00 |